Live feed
Filing
SC 13G
SC 13G0000935836-18-000365·Astria Therapeutics, Inc.
Schedule 13G ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P107
Event date: 2018-06-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,800,000
- Percent of class
- 6.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-18-000365
- Form type
- SC 13G
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jun 28, 2018
- Reporting period
- Jun 20, 2018
- Description
- Schedule 13G beneficial ownership